Clearside Biomedical

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CLSD and other ETFs, options, and stocks.

About CLSD

Clearside Biomedical, Inc. is a biopharmaceutical company that delivers therapies to the back of the eye through the suprachoroidal space. Its SCS microinjector enables a simple, repeatable, in-office procedure to deliver treatments directly to the macula, retina, or choroid, potentially helping to preserve and improve vision in patients with serious eye diseases.

CEO

George M. Lasezkay

CEOGeorge M. Lasezkay

Employees

Employees32

Headquarters

Alpharetta, Georgia

HeadquartersAlpharetta, Georgia

Founded

2011

Founded2011

Employees

Employees32

CLSD Key Statistics

Market cap

31.77M

Market cap31.77M

Price-Earnings ratio

-1.48

Price-Earnings ratio-1.48

Dividend yield

—

Dividend yield—

Average volume

509.68K

Average volume509.68K

High today

$0.6399

High today$0.6399

Low today

$0.3902

Low today$0.3902

Open price

$0.58

Open price$0.58

Volume

3.65M

Volume3.65M

52 Week high

$1.65

52 Week high$1.65

52 Week low

$0.3201

52 Week low$0.3201

CLSD News

TipRanks 13h

Clearside Biomedical downgraded to Neutral from Buy at H.C. Wainwright

H.C. Wainwright downgraded Clearside Biomedical (CLSD) to Neutral from Buy without a price target after the company said it is exploring strategic alternatives....

TipRanks 1d

Clearside Biomedical downgraded to Hold from Buy at Needham

Needham downgraded Clearside Biomedical (CLSD) to Hold from Buy with a $3 price target Published first on TheFly – the ultimate source for real-time, market-mo...

Analyst ratings

86%

of 7 ratings

Buy

14.3%

Hold

85.7%

Sell

People also own

Based on the portfolios of people who own CLSD. This list is generated using Robinhood data, and it’s not a recommendation.